fda semaglutide compounding enforcement october 2025 Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about compounded GLP-1 medications Did the FDA Ban Compounded

Diabetes 60, 218226

Growth opportunities are concentrated in partnerships with health food retailers, premium placement in specialty tea outlets, and the development of organic or fusion products tailored to local tastes, such as blends incorporating Mediterranean herbs

Biomed Pharmacother = Biomed Pharmacother (2020) 130:110519

Expanding market access through regulatory gray zones can accelerate short-term revenue for telehealth platforms, but real long-term moat in bio-health still requires undeniable clinical validation I have been watching, and am not sure that the 2+ hour deliberations have moved the voting needles much